Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Domains specifying thrombin-receptor interaction.

T K Vu1, V I Wheaton, D T Hung

  • 1Cardiovascular Research Institute, University of California, San Francisco 94143-0524.

Nature
|October 17, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance.

Biochimica et biophysica acta. Molecular cell research·2022
Same author

Institutionalising wastewater surveillance systems to minimise the impact of COVID-19: cases of Indonesia, Japan and Viet Nam.

Water science and technology : a journal of the International Association on Water Pollution Research·2021
Same author

Thrombin receptor function and cardiovascular disease.

Trends in cardiovascular medicine·2011
Same author

Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice.

Atherosclerosis·2009
Same author

Cardiovascular and metabolic effects of CPAP in obese males with OSA.

The European respiratory journal·2007
Same author

Protease-activated receptors in hemostasis, thrombosis and vascular biology.

Journal of thrombosis and haemostasis : JTH·2005
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
See all related articles

Researchers engineered a novel thrombin receptor activated by enterokinase, not thrombin. This study reveals key insights into thrombin receptor activation and potential new drug targets for thrombosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Platelet activation by thrombin is crucial in arterial thrombosis.
  • The platelet thrombin receptor (PAR1) is a seven transmembrane domain receptor.
  • Thrombin cleaves the receptor's extracellular domain to initiate signaling.

Purpose of the Study:

  • To investigate the essential elements for thrombin receptor activation.
  • To engineer a modified thrombin receptor with altered activation properties.
  • To elucidate the structural basis for thrombin's high affinity and potency.

Main Methods:

  • Site-directed mutagenesis to replace the thrombin cleavage site with an enterokinase cleavage site.
  • Functional assays to measure receptor activation by enterokinase and thrombin.

Related Experiment Videos

  • Structural analysis to identify domains involved in thrombin binding.

    • Main Results:

    • A functional enterokinase receptor was successfully created, demonstrating proteolysis is sufficient for activation.
    • The engineered receptor required nanomolar enterokinase concentrations, unlike picomolar thrombin for the wild-type receptor.
    • A specific receptor domain, mimicking hirudin's carboxyl tail, was identified as critical for thrombin's potent binding via its anion-binding exosite.

    Conclusions:

    • Receptor proteolysis is the sole determinant for thrombin receptor activation.
    • A model for thrombin-receptor interaction was established, highlighting a hirudin-like domain.
    • This model facilitates the design of novel thrombin inhibitors for thrombosis treatment.